Chronic and subacute phenylalanine effects on brain metabolism in adults with phenylketonuria
Brain · 17.11.2026
DOI: 10.1093/brain/awag362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 17.11.2026. Verfasst von Raphaela Muri und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Phenylketonuria (PKU) leads to chronic cerebral exposure to elevated phenylalanine (Phe) despite lifelong dietary treatment, yet the neurometabolic consequences in adulthood remain incompletely understood. We investigated whether adults with early-treated PKU exhibit persistent alterations in brain metabolism and whether these metabolites respond dynamically to subacute Phe fluctuations. Adults with early-treated PKU (n=30) and healthy controls (n=59) underwent proton magnetic resonance spectroscopy (1H-MRS), structural and functional brain MRI to evaluate white matter lesion load (T2-weighted images) and cerebral blood flow (arterial spin labeling), as well as cognitive assessments. Patients additionally participated in a randomized, placebo-controlled crossover intervention with four weeks of oral Phe loading to evaluate subacute metabolic responsiveness. Absolute metabolite concentrations were quantified in predominantly white matter tissue, and associations between blood and brain Phe, white matter lesion load, cerebral blood flow, and cognitive performance were examined. At baseline, patients exhibited higher brain Phe and N-acetylaspartate (NAA) levels, alongside reduced myo-inositol, N-acetylaspartylglutamate (NAAG), and total creatine/phosphocreatine compared with controls. Patients with white matter lesions did not differ in blood and brain metabolites from those without. Four weeks of oral Phe loading increased brain Phe and produced a reversible decrease in myo-inositol, whereas NAA, NAAG, and creatine compounds remained unchanged. Blood and brain Phe concentrations were strongly correlated (r=0.83, p<0.001), and their ratio was subject-dependent. No significant associations were observed between metabolite concentrations and regional cerebral blood flow or cognitive performance after correction for multiple comparisons. Adults with early-treated PKU exhibit persistent neurometabolic alterations involving neuronal–glial metabolism, energy buffering, and astrocytic osmolyte regulation. The findings support a trait–state framework, with stable alterations in NAA, NAAG, and creatine compounds reflecting long-standing metabolic changes, superimposed on a dynamically Phe-sensitive astrocytic response indexed by myo-inositol. The absence of strong associations with cerebral perfusion or cognition suggests that these alterations represent upstream biological processes not captured by macroscopic imaging or behavioral measures.
Zitieren
APA
Muri, R., Hoefemann, M., Vallesi, V., Winiger, L., Zwygart, K., Hochuli, M., Trepp, R., Everts, R., & Kreis, R. (2026). Chronic and subacute phenylalanine effects on brain metabolism in adults with phenylketonuria. Brain. https://doi.org/10.1093/brain/awag362
Vancouver
Muri R, Hoefemann M, Vallesi V, Winiger L, Zwygart K, Hochuli M, et al. Chronic and subacute phenylalanine effects on brain metabolism in adults with phenylketonuria. Brain. 2026. doi:10.1093/brain/awag362
BibTeX
@article{Muri2026,
author = {Muri, Raphaela and Hoefemann, Maike and Vallesi, Vanessa and Winiger, Laura and Zwygart, Karin and Hochuli, Michel and Trepp, Roman and Everts, Regula and Kreis, Roland},
title = {Chronic and subacute phenylalanine effects on brain metabolism in adults with phenylketonuria},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awag362}
}
EUVIMED